Skip to main content

Perrigo Company Value Stock - Dividend - Research Selection

Perrigo

ISIN: IE00BGH1M568 , WKN: A1XAEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Perrigo: The Rebound Is Just Getting Started

2026-08-13
Perrigo's recent quarterly EPS and revenue beats, coupled with market share gains, signal improving fundamentals. Read why PRGO stock is a Buy.

Perrigo Company plc (PRGO) Q2 2026 Earnings Call Transcript

2026-08-05
Perrigo Company plc (PRGO) Q2 2026 Earnings Call August 5, 2026 8:30 AM EDTCompany ParticipantsEric Jacobson - Vice President of Global Investor...

12 Health Care Stocks Moving In Wednesday's Intraday Session

2026-08-05
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX) shares

Perrigo Company plc 2026 Q2 - Results - Earnings Call Presentation

2026-08-05
2026-08-05. The following slide deck was published by Perrigo Company plc in conjunction with their 2026 Q2 earnings call.

Perrigo (NYSE:PRGO) Beats Q2 Earnings Estimates, Shares Surge 7%

2026-08-05
Perrigo (PRGO) Q2 earnings beat with non-GAAP EPS of $0.50 vs $0.35 expected, revenue nearly inline; stock up 7% premarket.

Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday

2026-08-05
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies recording gains in today's session.

Perrigo Affirms FY2026 Adj EPS Guidance of $2.25-$2.55 vs $2.11 Est; Affirms FY2026 Sales Guidance of $4.019B-$4.189B vs $4.056B Est

2026-08-05
Perrigo (NYSE:PRGO) affirms FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.55 vs $2.11 analyst estimate. Affirms FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.019 billion-$4.189 billion vs $4.056

Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate

2026-08-05
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.34 by 47.06 percent. This is a 12.28 percent decrease over earnings of $0.57 per share from the same

Perrigo Announces Quarterly Dividend

2026-07-30
Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on September 15, 2026, to shareholders of record on August 28, 2026.

Perrigo to Present at the Canaccord 46th Annual Growth Conference

2026-07-29
Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to present at the Canaccord 46th Annual Growth Conference, on Wednesday, August 12th at 10:30 AM EDT.